On March 22, 2024, DIAGNOS Inc closed the transaction. The company issued 650,000 units at an issue price of CAD 0.28 per Unit for gross proceeds of CAD 182,000 under second and final tranche. Each Unit consists of One common share and One common share warrant. Each Warrant can be exercised to purchase one Share at a price of CAD 0.40 per Share for a period of 18 months ending September 22, 2025. The company has paid finder's fees of CAD 7,840 and issued aggregate number of 28,000 finder?s warrants to two qualified firms acting at arm?s length (each a ?Finder?). Each finder?s warrant entitles the Finder to purchase one Share at an exercise price of CAD 0.40 per Share for a period of 18 months ending September 22, 2025. All securities issued as part of the second and final tranche of the Private Placement are subject to a statutory hold period ending July 23, 2024.
On April 2, 2024, the company announced that the The TSX Venture Exchange has accepted for filing documentation with respect to a non-brokered private placement. The transaction included participation from 6 placees.